US · guidance
CMS SOM App. C, Tag D5203
§493.1232 Standard: Specimen identification and integrity
The laboratory must establish and follow written policies and procedures that
ensure positive identification and optimum integrity of a patient’s specimen from
the time of collection or receipt of the specimen through completion of testing and
reporting of results.
Interpretive Guidelines §493.1232
The regulation provides laboratories the flexibility to establish a system that ensures
positive patient identification through specimen collection, labeling, accessioning,
processing, (e.g., aliquoting), storage, testing, and reporting of results. Review the
laboratory’s system (policy and practices) for ensuring positive patient identification
from specimen collection through reporting of results.
Optimum integrity of a patient’s specimen is determined according to the test
methodology utilized by the laboratory and the manufacturer’s instructions. Review the
manufacturer’s instructions for performance of each test method to ensure the specimen
is appropriate for the test system, is stored and preserved properly (e.g., maintained at
room temperature, kept on ice, separated and frozen or refrigerated), and analyzed within
the limitations of the test methodology. For specimen integrity problems in the
preanalytic system, see also D5311.
The laboratory must have a procedure to ensure that special handling of specimens is
maintained throughout the testing process when necessary (e.g., GC cultures and
GC/Chlamydia probes, blood gas specimens, and DNA probes).
Probes §493.1232
How does the laboratory ensure positive identification of patient specimens through all
phases of testing, especially when similar patient identification information (e.g., address,
sex, names, timed specimens, and birth dates) exists?
How does the laboratory ensure that special handling of specimens (as specified in the
laboratory’s procedure manual) is maintained throughout the testing process?
Does the laboratory process patient specimens using separate (distinct) or unique
identifiers in order to avoid mislabeling, specimen mix-ups, incorrect test request entry,
incorrect entry of test results in the Laboratory Information System (LIS), and incorrect
reporting of results?
History
Rev. 233; Issued: 09-12-25; Effective: 09-12-25; Implementation: 09-12-25
Provenance
- Source
- cms.gov
- Retrieved
- 2026-07-22
- Edition
- som-2026-07-22
- Content hash
e7f836d7c7eb00f168dc47b168f0cc0f9422c6565735d37ee7d50ac1f164c9df
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.